Inhibitor Therapeutics, Inc. Retained Earnings
Inhibitor Therapeutics, Inc. (INTI) had Retained Earnings of -$56.72 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$56.72M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$56.11M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$55.42M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$54.12M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$56.72M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$56.11M 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$55.42M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$54.12M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$53.41M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$52.75M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$52.12M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$50.70M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$49.97M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$49.46M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$48.78M 10-K · filed 2025-03-28 |
| 2023-09-30 | -$47.61M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$46.95M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$46.29M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$45.75M 10-K · filed 2024-03-29 |
| 2022-09-30 | -$58.07M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$57.95M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$57.82M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$57.67M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$57.59M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$57.47M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$57.35M 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$57.17M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$57.07M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$56.71M 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$56.35M 10-Q · filed 2020-05-01 |
| 2019-12-31 | -$55.91M 10-K · filed 2021-03-26 |
| 2019-09-30 | -$55.23M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$54.50M 10-Q · filed 2019-08-12 |
| 2019-03-31 | -$53.82M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$52.98M 10-K · filed 2020-03-30 |
| 2018-09-30 | -$51.60M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$50.38M 10-Q · filed 2018-07-23 |
| 2018-03-31 | -$49.47M 10-Q · filed 2018-05-01 |
| 2017-12-31 | -$48.27M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$47.37M 10-Q · filed 2017-10-31 |
| 2017-06-30 | -$46.69M 10-Q · filed 2017-07-31 |
| 2017-03-31 | -$45.97M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$43.17M 10-K · filed 2018-02-16 |
| 2016-09-30 | -$40.42M 10-Q · filed 2016-10-31 |
| 2016-06-30 | -$38.70M 10-Q · filed 2016-08-12 |
| 2016-03-31 | -$37.37M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$36.17M 10-K · filed 2017-02-17 |
| 2015-09-30 | -$35.14M 10-Q · filed 2015-11-04 |
| 2015-06-30 | -$33.94M 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$33.15M 10-Q · filed 2015-05-13 |
| 2014-12-31 | -$32.22M 10-K · filed 2016-02-01 |
| 2014-09-30 | -$31.32M 10-Q · filed 2014-10-10 |
| 2014-06-30 | -$30.58M 10-Q · filed 2014-08-13 |
| 2014-03-31 | -$28.44M 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$28.25M 10-K · filed 2015-02-13 |
| 2013-09-30 | -$28.03M 10-Q · filed 2013-11-14 |
| 2012-12-31 | -$26.41M 10-K · filed 2014-04-15 |